Cohen JA. 2017 proposed revisions to the McDonald diagnostic criteria for multiple sclerosis. ECTRIMS 2017, 93.
Extra voordeel langere dosisinterval natalizumab: minder JCV-conversie
mei 2025 | Multipele Sclerose
jan 2024 | Neuro-vasculair
dec 2023 | Bewegingsstoornissen